🚀 Special offer for our LEVITY audience: Join Vitalism today and receive a 30% discount on your membership using the code LEVITY at checkout. https://www.vitalism.io/membership

🚀 Show notes for this episode will be available soon after this airs. Sign up for the LEVITY newsletter to get them straight to your inbox: https://peterottsjo.beehiiv.com/

-- IN THIS EPISODE --

Nora Cavani, CEO of Alba Health, shares her journey from struggling with severe eczema and allergies to pioneering breakthrough solutions in children's gut health. After reversing her own chronic conditions through lifestyle changes, she learned how the first years of life critically shape our immune system, metabolism, and lifelong health through the gut microbiome.

As the first company to collaborate with leading microbiome research institutions, Alba Health uses cutting-edge metagenomics technology to analyze children's gut bacteria and provide personalized recommendations. Cavani explains why modern factors like C-sections, antibiotics, and processed foods are leading to a concerning loss of essential gut bacteria in Western children - with many babies now lacking microbes crucial for immune development.

Learn how the gut microbiome affects everything from common childhood ailments to chronic disease risk, why diversity in diet matters, and practical steps parents can take during the critical early window of their child's development. A vital conversation for parents, health optimizers, and anyone interested in preventing chronic disease through early intervention.

-- CHAPTERS --

00:00 Introduction to Nora Cavani

05:08 Microbiome and child health

07:16 Nora’s journey from Italy to Sweden

10:43 Meeting the scientist and microbiologist Willem de Vos

15:20 Laying the groundwork for Alba Health

18:45 Gut microbiome is linked to afflictions in newborns

19:29 The ecosystem of the gut microbiome

21:00 The Ecosystem of the Gut Microbiome

28:33 Gut-brain axis

30:50 C-section and antibiotics

35:10 Alba's testing methodology and insights

41:38 Predicting health through microbiome analysis

45:23 The best time to take the test

54:20 Has Nora managed to get rid of her health issues?

57:19 The role of diet diversity in gut health

01:07:52 What can we still discover about the microbiome?

01:10:05 The role of exercise, sleep and stress in adults

01:12:40 Child health and longevity

01:16:40 Nora’s personal longevity regimen and testing

01:23:36 Oura’s investment i Alba Health

01:28:18 Future of microbiome research

01:32:28 Scientific consensus and controversy

01:43:37 The future for Alba Health

01:45:52 How to get in touch with Nora and Alba

Hosted on Acast. See acast.com/privacy for more information.

🚀 Special offer for our LEVITY audience: Join Vitalism today and receive a 30% discount on your membership using the code LEVITY at checkout. https://www.vitalism.io/membership

🚀 Show notes for this episode will be available soon after this airs. Sign up for the LEVITY newsletter to get them straight to your inbox: https://peterottsjo.beehiiv.com/

🚀 Looking for LEVITY Merch? https://levity-7.creator-spring.com/

Sergey Jakimov is a founding partner of LongeVC, a VC fund supporting early-stage biotech and longevity-focused founders who are changing the world.

Hosted on Acast. See acast.com/privacy for more information.

🚀 Special offer for our LEVITY audience: Join Vitalism today and receive a 30% discount on your membership using the code LEVITY at checkout. https://www.vitalism.io/membership

🚀 Show notes for this episode will be available soon after this airs. Sign up for the LEVITY newsletter to get them straight to your inbox: https://peterottsjo.beehiiv.com/

Niklas Anzinger is the founder of Infinita VC based in the charter city of Prospera in Honduras. He is the co-founder of Vitalia, a longevity focused community. His fund Infinita focuses on a new trend of charter cities and other forms of alternative jurisdictions. He also hosts a podcast about how to accelerate the future by unblocking “stranded technologies”.

Hosted on Acast. See acast.com/privacy for more information.

🚀 Special offer for our LEVITY audience: Join Vitalism today and receive a 30% discount on your membership using the code LEVITY at checkout. https://www.vitalism.io/membership

🚀 Show notes for this episode will be available soon after this airs. Sign up for the LEVITY newsletter to get them straight to your inbox: https://peterottsjo.beehiiv.com/

When I first met Emil Kendziorra at the Longevity Biotech Fellowship retreat in Sweden, I found myself captivated by his ability to explain every aspect of cryopreservation for hours. His deep knowledge, combined with his remarkable skill in communicating complex ideas, made me realize this conversation needed to reach a broader audience.

In this comprehensive episode, Emil, CEO of Tomorrow Bio, takes us through the fascinating world of cryopreservation, leaving no stone unturned. We explore:

• The science behind cryopreservation and how it differs from simple freezing
• The history of cryonics and its evolution into modern cryopreservation
• Step-by-step details of the preservation process
• The logistics of emergency response and stabilization
• Long-term storage solutions and safety measures
• The challenges and possibilities of future revival
• Ethical considerations and philosophical implications
• The current state of research and future developments
• Practical aspects of signing up and funding
• Common misconceptions and concerns

Whether you're curious about cryopreservation as a backup plan for longevity or simply interested in understanding this fascinating field, this episode provides a comprehensive overview of what might be our best bridge to a longer-lived future.

Hosted on Acast. See acast.com/privacy for more information.

🚀 Special offer for our LEVITY audience: Join Vitalism today and receive a 30% discount on your membership using the code LEVITY at checkout. https://www.vitalism.io/membership#mobilize-sign-up

🚀 Show notes for this episode will be available shortly after this airs. Sign up for the LEVITY newsletter to get them straight to your inbox: https://peterottsjo.beehiiv.com/

Todays guest is another California resident, distinguished Professor John Martin Fisher at University of California Riverside. Professor Fischer has as worked on the metaphysics of death and philosophy of religion and led a multi-year, multi-pronged research project on "immortality," funded in 2012 by the John Templeton Foundation. 

He is the author of several books including Death, Immortality, and Meaning in Life. (Oxford University Press, 2019). And Near-Death Experiences: Understanding Visions of the Afterlife (co-authored with Benjamin Mitchell-Yellin) (Oxford University Press, 2016)

Learn about:

✅ Near-death experiences

✅ The fear of death

✅ The desirability of immortality

Hosted on Acast. See acast.com/privacy for more information.

🚀 Special offer for our LEVITY audience: Join Vitalism today and receive a 30% discount on your membership using the code LEVITY at checkout. https://www.vitalism.io/membership#mobilize-sign-up

🚀 Show notes for this episode will be available Wednesday Oct 2. Sign up for the LEVITY newsletter to get them straight to your inbox: https://peterottsjo.beehiiv.com/

Longevity superstar Bryan Johnson made waves when he traveled to the Bahamas for a stem cell treatment. But who's behind this cutting-edge therapy? Meet Maria Rankka, co-founder of Cellcolabs, the Swedish startup that's caught the attention of one of the world's biggest longevity influencers.

In this episode of LEVITY, hosts Peter Ottsjö and Patrick Linden dive deep into Cellcolabs' ambitious mission: to revolutionize healthcare by producing cheap and abundant mesenchymal stromal cells (MSCs). Could this be the key to combating inflammation and extending healthspan on a global scale?

Maria Rankka shares the inside story of Cellcolabs' journey, from its inception during the COVID-19 pandemic to its current position at the forefront of regenerative medicine.

Learn about:

✅ The science behind MSCs and why they're creating buzz in longevity circles

✅ Cellcolabs' innovative approach to scaling stem cell production

✅ Maria's personal experience with MSC treatment

✅ The potential of MSCs to transform preventative medicine

✅ Making regenerative treatments accessible to the masses

Hosted on Acast. See acast.com/privacy for more information.

This is one of the most amazing new discoveries: We can rejuvenate cells. Next step is to rejuvenate entire organisms, and ultimately human beings including our brains. Yuri Deigin, CEO of YouthBio Therapeutics, is a pioneering drug developer and longevity maximalist currently working on partial reprogramming gene therapies for Alzheimer’s and other diseases.

Hosted on Acast. See acast.com/privacy for more information.

There are countless reasons to admire Mark Hamalainen, and one of them is his brutal honesty. While many longevity influencers confidently declare that longevity escape velocity and indefinite lifespans are just around the corner, you won’t get such easy assurances from Mark.

That’s because, and this might seem counterintuitive at first, he’s one of the most deeply committed advocates for solving aging that I’ve encountered. Mark, a former director of science at Synthego and a former researcher at SENS Research Foundation (Aubrey de Grey has called him his protégé), has dedicated over two decades to tackling humanity’s greatest challenge.

You see, Mark's honesty doesn't stem from pessimism, but from a deep commitment to reality-based thinking. His mission isn’t driven by hype but by a relentless pursuit of tangible progress in the fight against aging.

I (Peter) first met Mark at the Longevity Biotech Fellowship (LBF) retreat in Sweden in January 2024, where I had the opportunity to witness his vision and dedication firsthand. It left a lasting impression, not only on me but likely on everyone who attended. Here was someone who wasn’t just dreaming about a future where aging is solved - he was meticulously planning it, working hard to remove the roadblocks that stand in the way.

His work with the LBF, the Longevity Acceleration Roadmap, and his broader efforts in the longevity community are all about taking concrete, actionable steps toward a future where the passing of time is not a death sentence - all the while knowing that this goal is one of the most complex challenges humanity has ever faced.

In this episode, Mark discusses several key strategies that he believes are essential to making real progress. These include advancing bioengineering to gain precise control over biological processes, developing comprehensive data sets to better understand aging at a molecular level, and exploring visionary ideas like the replacement strategy. He also highlights the potential of biostasis and cryopreservation as a last resort, potentially offering a way to preserve life until future technologies can fully reverse aging.

So, while Mark may not offer the easy assurances that some in the longevity space do, he offers something far more valuable: a realistic and deeply informed plan of action, a commitment to truth over convenience, and above all, a profound hope that by facing the realities of aging head-on, we can one day overcome them.

Hosted on Acast. See acast.com/privacy for more information.

In this podcast we are not only concerned with how we can prolong human life, but also whether it is a good idea, morally speaking.

Professor John K. Davies of California State University in Fullerton. He has written a book called New Methuselahs - the ethics of life extension published by MIT Press in 2018. In it he defends the conclusion that life extension science should be promoted.

He has been quoted on life extension in interviews with The Daily Beast, Science News, Newsweek, The Financial Times of London, Canadian Broadcasting Corporation, and Allure Magazine, among other places.

Hosted on Acast. See acast.com/privacy for more information.

Prof. Alexandra Stolzing is a pioneer in biogerontological engineering at Loughborough University. With over two decades of experience, including work at SENS Research Foundation, Prof. Stolzing shares insights on:

Targeting senescent cells for anti-aging therapies

Revolutionizing cryopreservation techniques

Developing breath-based aging biomarkers

Harnessing AI for rapid drug discovery in aging research

Learn how her journey from Germany to the UK shaped her multidisciplinary approach to solving aging. Discover the challenges and opportunities in longevity research, including the critical need for basic science funding.

Show notes here: https://peterottsjo.beehiiv.com/

Hosted on Acast. See acast.com/privacy for more information.